Aug 2026· Archives of Microbiology· Vol 208· 0 citations· 238 references
Medicine
TL;DR
This study investigates the CRISPR-Cas framework’s potential as a cutting-edge tactic to fight antimicrobial resistance, and finds that the efficiency of CRISPR-Cas is diminished in some bacterial strains due to variations in their CRISPR loci.
Overall, CRISPR-based antimicrobial therapy represents a transformative approach to precision infectious disease management, with continued technological innovation, interdisciplinary collaboration, and robust clinical validation expected to facilitate its safe, effective, and clinically accessible implementation again...
Dipankar Mukhopadhyay, Dr. Shilanjali Bhalerao, Dr. Vijayendra Gautam et al.· Genetics and Molecular Resea...· 0 citations
This review critically examines bacteriophage-based antimicrobials, CRISPR-Cas therapeutic systems, and their emerging integration as CRISPR-armed phages, highlighting their comparative advantages, current limitations, and future potential as promising targeted antimicrobial approach platforms requiring further clinica...
Anjaneyulu Musini, V. Yata, Sarad Pawar Naik Bukke et al.· Molecular Biology Reports· 0 citations
DNA repair is established as a programmable determinant of CRISPR-Cas antifungal activity and provide a mechanistic framework for combinatorial targeting strategies, advancing the development of CRISPR-Cas antifungals.
Christopher J. Cotter, C. Trinh· bioRxiv· 0 citations
Four convergent, non-traditional pillars emerged — programmable CRISPR-Cas and CRISPRi genomic tools, monoclonal antibodies and bioconjugates, antimicrobial and anticancer peptides, and stimuli-responsive nanozymes and exosomal carriers — each capable of bypassing classical resistance mechanisms while, at least in prec...
In vivo models confirm significant reduction of resistant pathogens, supporting clinical translational potential and key challenges remain in off-target effects, manufacturing, and regulatory approval for human use.
Mahsa Khosrojerdi, S. Hashemi, Reza Besharati et al.· Virus Research· 0 citations
Recent advances in antimicrobial nanomaterials, nanodrug delivery systems, antibiofilm strategies, and nanodiagnostics are summarized and the potential of nanotechnology to support sustainable AMR management across interconnected human, animal, and environmental sectors is emphasized.